Citadel Advisors
NUVA

Citadel Advisors’s NuVasive, Inc. NUVA Stock Holding History

Citadel Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$4.16K – 15506
2023
Q2 		$4.16K Hold
100
– – ﹤0.01% 13626
2023
Q1 		$4.13K Sell
100
-1,700
-94% -$72.7K ﹤0.01% 13980
2022
Q4 		$74.2K Buy
+1,800
New +$72.9K ﹤0.01% 11635
2022
Q2 		– Sell
-10,200
Closed -$578K – 14545
2022
Q1 		$578K Sell
10,200
-2,200
-18% -$117K ﹤0.01% 9049
2021
Q4 		$651K Buy
12,400
+600
+5% +$32.6K ﹤0.01% 9026
2021
Q3 		$706K Sell
11,800
-4,000
-25% -$247K ﹤0.01% 9048
2021
Q2 		$1.07M Sell
15,800
-9,700
-38% -$662K ﹤0.01% 8202
2021
Q1 		$1.67M Sell
25,500
-31,400
-55% -$1.88M ﹤0.01% 6838
2020
Q4 		$3.21M Buy
56,900
+28,900
+103% +$1.42M ﹤0.01% 4486
2020
Q3 		$1.36M Sell
28,000
-49,400
-64% -$2.66M ﹤0.01% 5455
2020
Q2 		$4.31M Buy
77,400
+57,100
+281% +$3.3M ﹤0.01% 3292
2020
Q1 		$1.03M Buy
20,300
+11,300
+126% +$758K ﹤0.01% 5291
2019
Q4 		$696K Sell
9,000
-800
-8% -$56.5K ﹤0.01% 6257
2019
Q3 		$621K Sell
9,800
-4,700
-32% -$294K ﹤0.01% 6390
2019
Q2 		$849K Sell
14,500
-19,600
-57% -$1.16M ﹤0.01% 5959
2019
Q1 		$1.94M Buy
34,100
+20,200
+145% +$1.07M ﹤0.01% 4524
2018
Q4 		$689K Buy
13,900
+2,500
+22% +$150K ﹤0.01% 5906
2018
Q3 		$809K Sell
11,400
-7,100
-38% -$452K ﹤0.01% 5909
2018
Q2 		$964K Buy
18,500
+8,700
+89% +$456K ﹤0.01% 5283
2018
Q1 		$512K Sell
9,800
-200
-2% -$10.1K ﹤0.01% 5847
2017
Q4 		$585K Buy
10,000
+600
+6% +$34K ﹤0.01% 5411
2017
Q3 		$521K Sell
9,400
-6,600
-41% -$437K ﹤0.01% 5269
2017
Q2 		$1.23M Buy
16,000
+2,500
+19% +$187K ﹤0.01% 3801
2017
Q1 		$1.01M Sell
13,500
-5,200
-28% -$377K ﹤0.01% 3978
2016
Q4 		$1.26M Sell
18,700
-15,900
-46% -$1.02M ﹤0.01% 3542
2016
Q3 		$2.31M Buy
34,600
+24,200
+233% +$1.54M ﹤0.01% 2803
2016
Q2 		$621K Buy
10,400
+6,100
+142% +$330K ﹤0.01% 4194
2016
Q1 		$209K Sell
4,300
-1,800
-30% -$81.7K ﹤0.01% 5584
2015
Q4 		$330K Sell
6,100
-2,200
-27% -$112K ﹤0.01% 5088
2015
Q3 		$400K Sell
8,300
-6,900
-45% -$357K ﹤0.01% 5125
2015
Q2 		$720K Buy
15,200
+12,000
+375% +$561K ﹤0.01% 4432
2015
Q1 		$147K Sell
3,200
-200
-6% -$9.29K ﹤0.01% 6512
2014
Q4 		$160K Sell
3,400
-3,100
-48% -$129K ﹤0.01% 6227
2014
Q3 		$227K Buy
6,500
+2,700
+71% +$96.1K ﹤0.01% 5599
2014
Q2 		$135K Sell
3,800
-5,400
-59% -$185K ﹤0.01% 5960
2014
Q1 		$353K Buy
9,200
+6,700
+268% +$246K ﹤0.01% 4823
2013
Q4 		$81K Sell
2,500
-2,000
-44% -$60.1K ﹤0.01% 5766
2013
Q3 		$110K Sell
4,500
-5,500
-55% -$135K ﹤0.01% 5286
2013
Q2 		$248K Buy
+10,000
New +$219K ﹤0.01% 4473

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Citadel Advisors's NUVA Position: Q3 2023 in Review

Citadel Advisors sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 10,460 shares — an estimated $435K sold.

Citadel Advisors first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $100M in Q4 2017. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Citadel Advisors reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 10,460 NuVasive, Inc. shares in Q3 2023, an estimated $435K.
  • Citadel Advisors first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Citadel Advisors's NuVasive, Inc. position peaked at $100M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.